Encintas, CA, United States of America

Niall O'donnell

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Niall O'Donnell: Innovator in Bile Acid Recycling Inhibitors

Introduction

Niall O'Donnell is a notable inventor based in the United States. He has made significant contributions to the field of medicine, particularly in the treatment of liver diseases. His innovative approaches focus on bile acid recycling inhibitors, which have the potential to improve patient outcomes.

Latest Patents

Although Niall O'Donnell currently holds 1 patents, his latest work includes groundbreaking methods for treating hypercholemia and cholestatic liver diseases. One of his notable inventions involves the use of Apical Sodium-dependent Bile Acid Transporter Inhibitors (ASBTIs) to ameliorate these conditions. This method aims to provide therapeutic benefits by effectively managing serum bile acid levels and reducing liver enzymes. Additionally, he has developed pediatric dosage forms for treating cholestatic liver diseases in children, ensuring that young patients receive appropriate care.

Career Highlights

Throughout his career, Niall O'Donnell has worked with prominent companies in the pharmaceutical industry. He has been associated with Ionis Pharmaceuticals, Inc. and Excaliard Pharmaceuticals, Inc., where he has contributed to the development of innovative treatments. His expertise in the field has positioned him as a valuable asset in the research and development of liver disease therapies.

Collaborations

Niall O'Donnell has collaborated with esteemed colleagues, including Nicholas M. Dean and J. Gordon Foulkes. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.

Conclusion

Niall O'Donnell's work in bile acid recycling inhibitors represents a significant advancement in the treatment of liver diseases. His innovative methods and collaborations highlight his commitment to improving patient care and outcomes. As he continues to develop new therapeutic approaches, his contributions to the field will undoubtedly have a lasting impact.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…